Bill > SB1214

This bill, titled the "Arizona Stem Cell Therapy Act," establishes regulations for stem cell and birth tissue therapies performed by physicians in Arizona. It prohibits the use of cells or tissues derived from aborted fetuses or embryos in these therapies. For therapies not yet approved by the U.S. Food and Drug Administration (FDA), physicians must ensure the stem cells or birth tissue are sourced from facilities registered or accredited by specific organizations, meet viability or composition criteria, and are accompanied by proper documentation. Physicians must also obtain informed consent from patients, clearly outlining the treatment's nature, lack of FDA approval, potential risks, benefits, and alternatives, and are required to include a specific disclosure in any advertisements for these therapies. Facilities providing these materials must maintain their accreditation and notify physicians of any changes. Violations can result in civil penalties of $10,000 per violation, and physicians who willfully violate the law, particularly by using materials from aborted fetuses or embryos, face felony charges and disciplinary action. The bill also defines key terms like "birth tissue therapy" and "stem cell therapy" and provides exceptions for physicians working under FDA investigational new drug approval or for institutions with specific accreditations.

Health and Social Services

https://apps.azleg.gov/BillStatus/BillOverview/84352